Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Toshinori Moritani"'
Autor:
Toshinori Moritani, Masanari Yoshimoto, Natsumi Hamada, Wakana Yamasuge, Noriko Minobe, Shoko Kosugi, Hitomi Matsuda, Akihiro Ishimoto, Takashi Kise, Daisuke Saji, Akihito Ito, Ayahito Kimura
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 95:2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38d3f24537cce92faa09f84c0c9fd530
https://doi.org/10.1254/jpssuppl.95.0_2-p-153
https://doi.org/10.1254/jpssuppl.95.0_2-p-153
Autor:
Hikari Takeshita, Koichi Yamamoto, Toshinori Moritani, Takashi Shimosato, Yoichi Takami, Hiromi Rakugi, Go Hamano
Publikováno v:
Journal of cardiovascular pharmacology. 73(5)
Sacubitril/valsartan was shown to attenuate the development of cardiac hypertrophy with enhanced blood pressure reduction compared with valsartan alone in animal models. We investigated whether a low-dose sacubitril/valsartan has blood pressure-indep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd5f638b5390c38442b80020b3b15682
https://pubmed.ncbi.nlm.nih.gov/30829732
https://pubmed.ncbi.nlm.nih.gov/30829732
Autor:
Hitomi Matsuda, Shoko Kosugi, Noriko Minobe, Toshinori Moritani, Kagari Kimura, Akihiro Ishimoto, Ayahito Kimura, Takeshi Iidaka
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 93:1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b5d5dc9621e79bcdf67ca66ca26d926
https://doi.org/10.1254/jpssuppl.93.0_1-p-060
https://doi.org/10.1254/jpssuppl.93.0_1-p-060
Autor:
Toshinori Moritani, Noriko Minobe, Hitomi Matsuda, Akihiro Ishimoto, Ayahito Kimura, Takeshi Iidaka
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 92:1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::faf6acd500ac7f6ddc769f9d9396d0d2
https://doi.org/10.1254/jpssuppl.92.0_1-p-125
https://doi.org/10.1254/jpssuppl.92.0_1-p-125
Autor:
Hitomi Kurinami, Takashi Shimosato, Ryuichi Morishita, Hironori Nakagami, Toshinori Moritani, Zhengda Pang, Munehisa Shimamura, Hiroshi Koriyama, Akiko Tenma
Publikováno v:
Hypertension research : official journal of the Japanese Society of Hypertension. 37(7)
Diabetes mellitus, hypertension and metabolic syndrome are major risk factors for the occurrence of cardiovascular events. In this study, we used spontaneous hypertensive rat (SHR)/NDmcr-cp (cp/cp) (SHRcp) rats as a model for metabolic syndrome to ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d1da168c9f4d8d4bbdffbcddf70e8eb
https://pubmed.ncbi.nlm.nih.gov/24621463
https://pubmed.ncbi.nlm.nih.gov/24621463
Autor:
Mariana Kiomy Osako, Hironori Nakagami, Toshinori Moritani, Ryuichi Morishita, Takashi Miyake, Hiroshi Koriyama, Hideo Shimizu, Takashi Shimosato, Futoshi Nakagami, Munehisa Shimamura
Publikováno v:
Experimental and therapeutic medicine. 2(5)
Treatment with angiotensin type 1 receptor blockers (ARBs) is known to improve renal dysfunction and glucose metabolism in obese diabetic animal models and humans. This study examined the effects of irbesartan, a unique ARB with PPARγ activation, on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5615cb067a286b2c00b8cf4e12ee20b9
https://pubmed.ncbi.nlm.nih.gov/22977605
https://pubmed.ncbi.nlm.nih.gov/22977605
Autor:
Futoshi Nakagami, Mariana Kiomy Osako, Toshinori Moritani, Munehisa Shimamura, Tomohiro Katsuya, Mariko Kyutoku, Takashi Shimosato, Noriko Minobe, Hideo Shimizu, Ryuichi Morishita, Hiroshi Koriyama, Hironori Nakagami, Takashi Miyake
Publikováno v:
Molecular medicine reports. 5(1)
Recent reports have shown that nifedipine, a calcium channel blocker, increases peroxisome proliferator-activated receptor-γ (PPARγ) activity. Since PPARγ agonists, such as pioglitazone and rosiglitazone, are effective in reducing non-alcoholic st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e611668257966254b812b295c412b85
https://pubmed.ncbi.nlm.nih.gov/21946918
https://pubmed.ncbi.nlm.nih.gov/21946918
Autor:
Takashi Shimosato, Noriko Minobe, Takashi Miyake, Futoshi Nakagami, Munehisa Shimamura, Toshinori Moritani, Hironori Nakagami, Ryuichi Morishita, Mariana Kiomy Osako, Hideo Shimizu, Yasushi Takeya
Publikováno v:
International Journal of Molecular Medicine. 26
The favorable metabolic effects of telmisartan have been attributed to its angiotensin II receptor blockade and action as a partial agonist of peroxisome proliferator-activated receptor (PPAR)-gamma. We previously reported that administration of telm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fbbf0e1cbd59e2a778533e75a51e9ee
https://doi.org/10.3892/ijmm_00000488
https://doi.org/10.3892/ijmm_00000488